Correction to: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer (Nature, (2024), 636, 8042, (474-480), 10.1038/s41586-024-08035-2)

Gabe S. Sonke; Annemiek van Ommen-Nijhof; Noor Wortelboer; Vincent van der Noort; Astrid C. P. Swinkels; Hedwig M. Blommestein; Cristina Guerrero Paez; Linda Mol; Aart Beeker; Karin Beelen; Lisanne C. Hamming; Joan B. Heijns; Aafke H. Honkoop; Paul C. de Jong; Quirine C. van Rossum-Schornagel; Christa van Schaik-van de Mheen; Jolien Tol; Cathrien S. Tromp-van Driel; Suzan Vrijaldenhoven; A. Elise van Leeuwen-Stok; SONIA Study Consortium

doi:10.1038/s41586-025-09406-z

Correction to: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer (Nature, (2024), 636, 8042, (474-480), 10.1038/s41586-024-08035-2)

Gabe S. Sonke^*
, Annemiek van Ommen-Nijhof
, Noor Wortelboer
, Vincent van der Noort
, Astrid C. P. Swinkels
, Hedwig M. Blommestein
, Cristina Guerrero Paez
, Linda Mol
, Aart Beeker
, Karin Beelen
, Lisanne C. Hamming
, Joan B. Heijns
, Aafke H. Honkoop
, Paul C. de Jong
, Quirine C. van Rossum-Schornagel
, Christa van Schaik-van de Mheen
, Jolien Tol
, Cathrien S. Tromp-van Driel
, Suzan Vrijaldenhoven
, A. Elise van Leeuwen-Stok

SONIA Study Consortium

^*Corresponding author for this work

Netherlands Cancer Institute
Erasmus University Rotterdam
Netherlands Comprehensive Cancer Organisation
Erasmus School of Health Policy & Management
Dutch Breast Cancer Society (BVN)
Spaarne Gasthuis
Rijnstate Hospital
Medical Centre Leeuwarden
Amphia
Isala Clinics
St. Antonius Ziekenhuis
Franciscus Gasthuis & Vlietland
Meander Medical Center
Jeroen Bosch Ziekenhuis
Gelre Ziekenhuizen
Northwest Hospital Group
BOOG Study Center
Amsterdam UMC

Research output: Contribution to journal › Comment/Letter to the editor › Academic

18 Downloads (Pure)

Abstract

Correction to: Naturehttps://doi.org/10.1038/s41586-024-08035-2 Published online 27 November 2024 In the version of the article initially published, in the “Histological subtype” section of Fig. 3, the hazard ratios and 99% confidence intervals between the “NST” and “Lobular” subgroups were switched. The figure has been corrected by reordering the subgroup rows to list “NST” first, followed by “Lobular”, as seen in Fig. 1. The “P for interaction” value remains unchanged. This correction has been made to the HTML and PDF versions of the article. (Figure presented.) “Histological subtype” row.

Original language	English
Pages (from-to)	E32
Journal	Nature
Volume	644
Issue number	8076
DOIs	https://doi.org/10.1038/s41586-025-09406-z
Publication status	Published - 14 Aug 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41586-025-09406-z

Correction-to.pdfFinal published version, 692 KBLicence: Taverne

Cite this

Sonke, G. S., van Ommen-Nijhof, A., Wortelboer, N., van der Noort, V., Swinkels, A. C. P., Blommestein, H. M., Guerrero Paez, C., Mol, L., Beeker, A., Beelen, K., Hamming, L. C., Heijns, J. B., Honkoop, A. H., de Jong, P. C., van Rossum-Schornagel, Q. C., van Schaik-van de Mheen, C., Tol, J., Tromp-van Driel, C. S., Vrijaldenhoven, S., ... SONIA Study Consortium (2025). Correction to: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer (Nature, (2024), 636, 8042, (474-480), 10.1038/s41586-024-08035-2). Nature, 644(8076), E32. https://doi.org/10.1038/s41586-025-09406-z

@article{17707154f2d447e6a2e3afcc1d0fa804,

title = "Correction to: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer (Nature, (2024), 636, 8042, (474-480), 10.1038/s41586-024-08035-2)",

abstract = "Correction to: Naturehttps://doi.org/10.1038/s41586-024-08035-2 Published online 27 November 2024 In the version of the article initially published, in the “Histological subtype” section of Fig. 3, the hazard ratios and 99\% confidence intervals between the “NST” and “Lobular” subgroups were switched. The figure has been corrected by reordering the subgroup rows to list “NST” first, followed by “Lobular”, as seen in Fig. 1. The “P for interaction” value remains unchanged. This correction has been made to the HTML and PDF versions of the article. (Figure presented.) “Histological subtype” row.",

author = "Sonke, \{Gabe S.\} and \{van Ommen-Nijhof\}, Annemiek and Noor Wortelboer and \{van der Noort\}, Vincent and Swinkels, \{Astrid C. P.\} and Blommestein, \{Hedwig M.\} and \{Guerrero Paez\}, Cristina and Linda Mol and Aart Beeker and Karin Beelen and Hamming, \{Lisanne C.\} and Heijns, \{Joan B.\} and Honkoop, \{Aafke H.\} and \{de Jong\}, \{Paul C.\} and \{van Rossum-Schornagel\}, \{Quirine C.\} and \{van Schaik-van de Mheen\}, Christa and Jolien Tol and \{Tromp-van Driel\}, \{Cathrien S.\} and Suzan Vrijaldenhoven and \{van Leeuwen-Stok\}, \{A. Elise\} and \{SONIA Study Consortium\} and Konings, \{Inge R.\} and Agnes Jager",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature Limited 2025.",

year = "2025",

month = aug,

day = "14",

doi = "10.1038/s41586-025-09406-z",

language = "English",

volume = "644",

pages = "E32",

journal = "Nature",

issn = "0028-0836",

publisher = "Nature Publishing Group",

number = "8076",

}

Sonke, GS, van Ommen-Nijhof, A, Wortelboer, N, van der Noort, V, Swinkels, ACP, Blommestein, HM, Guerrero Paez, C, Mol, L, Beeker, A, Beelen, K, Hamming, LC, Heijns, JB, Honkoop, AH, de Jong, PC, van Rossum-Schornagel, QC, van Schaik-van de Mheen, C, Tol, J, Tromp-van Driel, CS, Vrijaldenhoven, S, van Leeuwen-Stok, AE & SONIA Study Consortium 2025, 'Correction to: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer (Nature, (2024), 636, 8042, (474-480), 10.1038/s41586-024-08035-2)', Nature, vol. 644, no. 8076, pp. E32. https://doi.org/10.1038/s41586-025-09406-z

TY - JOUR

T1 - Correction to

T2 - Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer (Nature, (2024), 636, 8042, (474-480), 10.1038/s41586-024-08035-2)

AU - Sonke, Gabe S.

AU - van Ommen-Nijhof, Annemiek

AU - Wortelboer, Noor

AU - van der Noort, Vincent

AU - Swinkels, Astrid C. P.

AU - Blommestein, Hedwig M.

AU - Guerrero Paez, Cristina

AU - Mol, Linda

AU - Beeker, Aart

AU - Beelen, Karin

AU - Hamming, Lisanne C.

AU - Heijns, Joan B.

AU - Honkoop, Aafke H.

AU - de Jong, Paul C.

AU - van Rossum-Schornagel, Quirine C.

AU - van Schaik-van de Mheen, Christa

AU - Tol, Jolien

AU - Tromp-van Driel, Cathrien S.

AU - Vrijaldenhoven, Suzan

AU - van Leeuwen-Stok, A. Elise

AU - SONIA Study Consortium

AU - Konings, Inge R.

AU - Jager, Agnes

PY - 2025/8/14

Y1 - 2025/8/14

N2 - Correction to: Naturehttps://doi.org/10.1038/s41586-024-08035-2 Published online 27 November 2024 In the version of the article initially published, in the “Histological subtype” section of Fig. 3, the hazard ratios and 99% confidence intervals between the “NST” and “Lobular” subgroups were switched. The figure has been corrected by reordering the subgroup rows to list “NST” first, followed by “Lobular”, as seen in Fig. 1. The “P for interaction” value remains unchanged. This correction has been made to the HTML and PDF versions of the article. (Figure presented.) “Histological subtype” row.

AB - Correction to: Naturehttps://doi.org/10.1038/s41586-024-08035-2 Published online 27 November 2024 In the version of the article initially published, in the “Histological subtype” section of Fig. 3, the hazard ratios and 99% confidence intervals between the “NST” and “Lobular” subgroups were switched. The figure has been corrected by reordering the subgroup rows to list “NST” first, followed by “Lobular”, as seen in Fig. 1. The “P for interaction” value remains unchanged. This correction has been made to the HTML and PDF versions of the article. (Figure presented.) “Histological subtype” row.

UR - https://www.scopus.com/pages/publications/105013590550

U2 - 10.1038/s41586-025-09406-z

DO - 10.1038/s41586-025-09406-z

M3 - Comment/Letter to the editor

C2 - 40696185

SN - 0028-0836

VL - 644

SP - E32

JO - Nature

JF - Nature

IS - 8076

ER -

Correction to: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer (Nature, (2024), 636, 8042, (474-480), 10.1038/s41586-024-08035-2)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this